
News
from the fight to #SaveIndiePharmacy
New York Times’ The Middlemen series

UnitedHealthcare CEO’s slaying brings criticism of U.S. insurance industry to a boiling point
Greater transparency from health insurers is sought as costs of insurance continue to grow faster than wages.

Rally outside Optum HQ brings debate over pharmacy benefits managers to Twin Cities
Patients, providers, and legislators gathered to allege biggest players are ballooning drug costs while running independent pharmacies out of business; Optum denied claims.

Minnesota legislation targets health insurers’ power to block medical care, medications
House bill would prevent redundant insurance red-tape for treatment of chronic diseases. The fate of prior authorization will be decided in the session’s final days.


HMO profits from Minnesota state programs jump to $675.8M with enrollment surge
Enrollees used less care than expected, and a state program to cap profits was no longer in place, leading to an increase of about 181% in operating income.
Drugmakers including Purdue Pharma paid pharmacy benefit managers not to restrict painkiller prescriptions, a New York Times investigation found.